* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Overview of Pituitary Syndromes
Survey
Document related concepts
Neuroendocrine tumor wikipedia , lookup
Hormone replacement therapy (menopause) wikipedia , lookup
Hormone replacement therapy (female-to-male) wikipedia , lookup
Vasopressin wikipedia , lookup
Bioidentical hormone replacement therapy wikipedia , lookup
Hypothyroidism wikipedia , lookup
Hormone replacement therapy (male-to-female) wikipedia , lookup
Graves' disease wikipedia , lookup
Hyperthyroidism wikipedia , lookup
Hyperandrogenism wikipedia , lookup
Kallmann syndrome wikipedia , lookup
Growth hormone therapy wikipedia , lookup
Hypothalamus wikipedia , lookup
Transcript
Overview of Pituitary Syndromes & Hypopituitarism General characteristic of Hormones They have specific rates and patterns of secretion (diurnal, pulsatile, cyclic patterns) Their secretion depends on feedback mechanism, either positive(rare) or negative They affect only cells with appropriate receptors Trophic Hormones: hormones that control the secretion of other endocrine glands eg. TRH, TSH, ACTH etc. Effector Hormones: produce an effect directly on target organs eg. ADH, T3, T4 etc. Pituitary gland Anatomy Histology Physiology Diseases of pituitary gland Anatomy of pituitary gland Pituitary gland lies in the base of the skull in a portion of sphenoid bone called sella turcica Master gland (controls the activity of many other endocrine glands) Controlled by the hypothalamus Consists of two lobes Anterior lobe (adenohypophysis) Posterior lobe (neurohypophysis) Measures 15X10X6 mm wt 500-900 mg It may double in size during pregnancy Normal Pituitary Anatomy Anatomy of pituitary gland Anterior lobe glandular tissue, accounts for 75% of total weight Hormones produced by this lobe are controlled by regulating hormones from the hypothalamus Posterior lobe More of a terminus of axons of neurons in the supraoptic and paraventricular nuclei of the hypothalamus does not produce hormones but stores those produced by the neurosecretory cells in the hypothalamus Release of hormones is triggered by receptors in the hypothalamus Histology of the Pituitary Gland Anterior pituitary cells were originally classified as Acidophilic cells Basophilic cells Chromophopic cells With immunocytochemical and electron microscopic techniques, classified by their secretary products Somatotrophs GH secreting cells Account about 50% of anterior P.G Acidophilic stained Lactotrophs Prl secreting cells acidophilic stained 10-15% of anterior PG Corticotrophs ACTH secretary cells basophilic cells 15-20% of anterior PG Gonadotrophs LH,FSH secretary cells basophilic staining 10-15% of anterior PG Thyrotrophs TSH secreting cells basophilic cells < 10% of anterior PG Anterior Pituitary Hormones Posterior Pituitary Hormones Antidiuretic hormone (ADH) or Vasopressin: vasoconstricts arterioles to increase arterial pressure; increases water reabsorption in distal tubules Oxytocin: stimulates uterus to contract at childbirth; stimulates mammary ducts to contract (milk ejection in lactation) Anterior Pituitary Disorders Hormone Increased level Decreased level GH Gigantism (child) Acromegaly (adult) Dwarfism (child) Lethargy, premature aging ACTH Cushing’s Disease Addison’s Disease TSH Secondary Hyperthyroidsm Secondary Hypothyroidsm Prolactin Galactorrhoea amenorrhea Failure to Lactate Late puberty, infertility FSH LH Menstrual cycle disturbance Amenorrhea, impotence Posterior Pituitary Disorders Hormone Increased Decreased Oxytocin Precipitates childbirth, excess milk Prolonged childbirth, diminished milk ADH (vassopressin) SIADH Diabetes Insipidus Anterior Pituitary Disorders Hypopituitarism: commonly caused by infarction, removal, or destruction of the gland by disease process Hyperpituitarism: almost always caused by pituitary adenoma Hypopituitarism Hypopituitrism is manifested by diminished or absent secretion of one or more PH Deficiency of all the pituitary hormones is called panhypopituitarism The development of signs and symptoms is often slow and insidious Hypopituitrism is either primary event caused by diseases of the pituitary gland or secondary to diseases of the hypothalamus (due to diminished secretion of hypothalamic releasing hormones) Treatment and prognosis depend on the extent of hypofunction and the underlying cause Causes of Hypopituitarism 1. Pituitary diseases Infarction postpartum necrosis (Sheehan syndrome) vascular disease head trauma Infections tuberculosis , fungi pyogenic , syphilis toxoplasmosis Pituitary Apoplexy Empty Sella syndrome Granulomatous disease Sarcoidosis Histiocytosis Infiltrative disease Autoimmune lymphocytic hypophysitis Hemochromatosis Neoplasm's involving pituitary Pituitary adenoma Craniopharyngioma Metastasis or primary carcinoma (rare) Aneurysm of internal carotid artery Idiopathic or genetic deficient production of pituitary hormone synthesis of abnormal hormone Iatrogenic stalk section radiation removal of pituitary adenoma Causes of hypopituitarism 2. Hypothalamic diseases Mass lesions benign (craniopharyngiomas) malignant tumors (metastatic from lung, breast, etc.) Infiltrative lesions – sarcoidosis Langerhans cell histiocytosis Radiation - for CNS and nasopharyngeal malignancies Infections - Tuberculous meningitis Developmental and genetic causes Septo-Optic dysplasia Kallman Syndrome Laurence-Moon-Bardet-Biedl Syndrome Frohlich Syndrome Head trauma Structural anomalies of hypothalamus Clinical Features of Hypopituitarism Can present with features of deficiency of one or more or all the pituitary hormones (called panhypopituitarism) Clinical presentation depends on: Age at onset Hormone effected Speed of onset Duration of the deficiency GH deficiency Deficiency in children lead to short stature Deficiency in adult may be asymptomatic or may present with nonspecific symptoms like fatigue, decreased muscle mass, loss of libido decreased bone mineral density, and increased risk of cardiovascular disease Insulin-like growth factor-I (IGF-I) is the major mediator of growth hormone (GH)-stimulated somatic growth IGF-I is synthesized in liver and secreted into the blood under the control of growth hormone Gonadotrophin deficiency (hypogonadism) In women Before Puberty - primary amenorrhea and failure of puberty development After Puberty - secondary amenorrhea and regression of secondary sexual characteristic, infertility In men Before Puberty - failure of puberty development After Puberty - decrease libido or impotence, loss of secondary sexual characteristic, infertility TSH deficiency Leads to Secondary Hypothyroidism Child – Cretinism Adult - Myxedema Clinical features cold intolerance dry skin loss of hair mental dullness Constipation increase in wt Bradycardia slow reflexes Hoarseness puffiness of the face ACTH deficiency Leads to secondary adrenocortical insufficiency (Addison’s Disease) Clinical features Weakness Nausea and vomiting Anorexia Wt loss Postural hypotension Hypoglycemia Hyponatremia Prolactin Deficiency Inability to lactate postpartum Often the 1st manifestation of Sheehan syndrome Sheehan's syndrome (postpartum hypopituitarism) a rare, but potentially life threatening, complication of severe post partum hemorrhage The pituitary gland is enlarged in pregnancy and prone to infarction from hypovolemic shock common presentation is failure to lactate and amenorrhea/oligomenorrhea, but any of the manifestations of hypopituitarism (eg, hypotension, hyponatremia, hypothyroidism) can occur anytime from the immediate postpartum period to years after delivery Diagnosis of Hypopituitarism Biochemical diagnosis of pituitary insufficiency Demonstrating low levels of trophic hormones in the setting of low target hormone levels Provocative/ stimulation tests may be required to assess pituitary reserve Tests Of Pituitary Sufficiency Hormone Test Normal response GH Insulin tolerance test: Regular insulin 0.1 uint/kg IV L-dopa 250-500 Arginine 0.5 gm Glucose <40 mg/dL; GH should be >3µg/L GH should be >3µg/L Prolactin TRH test: 200–500 µg IV Normal prolactin is >2 µg/L and increase >200% of baseline TSH Basal thyroid function tests: T4, T3, TSH TRH test: 200–500 µg IV Low free thyroid hormone levels in the setting of low TSH 5-10 fold increase in TSH Tests of Pituitary Sufficiency Hormone Test Normal response LH & FSH Basal LH, FSH, testosterone, estrogen levels GnRH test: GnRH (100 µg) IV Basal LH and FSH should be increased in postmenopausal women Low testosterone levels in the setting of low LH and FSH. LH should increase by 10 IU/L and FSH by 2 IU/L ACTH Insulin tolerance test: Regular insulin 0.1 uint/kg IV CRH test: 1ug/kg IV ACTH stimulation test: ACTH (Cosyntropin), 0.25 mg IM or IV Glucose <40 mg/dL Cortisol should increase by >7µg/dL or to >20 µg/dL. Basal ACTH increases two- to fourfold and peaks at 20–100 pg/mL. Normal response is cortisol >21 µg/dL Treatment of Hypopituitrism Deficient hormone Therapy TSH L-thyroxine 0.075–0.15 mg daily ACTH Hydrocortisone (10–20 mg A.M.; 5–10 mg P.M.) Cortisone acetate (25 mg A.M.; 12.5 mg P.M.) Prednisone (5 mg A.M.; 2.5 mg P.M.) LH & FSH Men :testosterone Women :cyclic estrogen and progesterone GH Adults: Somatotropin (0.1–1.25 mg SC qd) Children: Somatotropin (0.02–0.05 mg/kg per d) Growth Hormone Excess Mostly due to GH secreting pituitary adenoma Gigantism GH excess before closure of epipheseal growth plates of long bones Acromegaly GH excess after closure of epipheseal growth plates of long bones Insidious onset Usually diagnosed late Growth Hormone Excess May have DM or glucose intolerance Hypogonadism Large hands and feet Large head with a lowering brow and coarsening features Hypertensive – 25% Colon polyps 3-6 more likely than general population Multiple skin tags GIGANTISM ACROMEGALY Growth Hormone Excess Diagnosis Screen: Check for high IGF-I levels (>3 U/ml) Remember, levels very high during puberty Confirm: 100gm glucose load GH levels do not fall to <5ng/ml MRI or CT & visual field tests to determine size and position of the pituitary adenoma Treatment Surgical resection of adenoma Radiation Bromocriptine - temporary measure May decrease GH by 50% Somatostatin (Octreotide) For suboptimal response to other treatment Posterior Pituitary Disorders SIADH & Diabetes Insipidus are major disorders of the posterior pituitary……however Even if posterior lobe becomes damaged, hormonal deficiencies usually do not develop because……?? SIADH (Syndrome of Inappropriate Anti-Diuretic Hormone) Too much ADH produced or secreted. SIADH commonly results from malignancies, CHF, & CVA - resulting in damage to the hypothalamus or pituitary which causes failure of the feedback loop that regulates ADH. Patient retains water causing dilutional hyponaetremia & decreased osmolality. Decreased serum osmolality cause water to move into cells Signs and Symptoms Lethargy & weakness Confusion or changes in neurological status Cerebral edema Muscle cramps Decreased urine output Weight gain without edema Hypertension Assessment Serum sodium low Serum osmolality low Urine osmolality disproportionately elevated in relation to the serum osmolality Urine specific gravity elevated Plasma ADH elevated Treatment of SIADH Treat underlying cause Hypertonic or isotonic IV saline solution Monitor for signs of fluid and electrolyte imbalance Monitor for neurological effects Monitor intake and output Weigh Restrict fluid intake Lithium inhibits action of ADH to promote water excretion. Diabetes Insipidus (DI) Etiology Deficiency in secretion of ADH Agenesis or irreversible destruction of the neurohypophysis Malformation or destruction of the neurohypophysis by a variety of diseases or toxins Neurohypophyseal DI, Pituitary DI, or Central DI Deficiency in action of ADH Can be genetic, acquired, or caused by exposure to various drugs Nephrogenic DI Clinical Manifestations Polyuria of more than 3 litres per 24 hours in adults (may be up to 20!) Urine specific gravity low Polydipsia (excessive drinking) Weight loss Dry skin & mucous membranes Possible hypovolemia, hypotension, electrolyte imbalance Diagnostic Tests Serum sodium may be high Urine specific gravity low Urine osmolality low Water deprivation test In DI water deprivation does not result in urine concentration Differentiating b/w Neurogenic vs Nephrogenic DI Administer Desmopressin (DDAVP) Measure urine osmolality at 30,60,120 min An increase of >50% indicates severe pituitary DI Smaller or absent response is strongly suggestive of nephrogenic DI Treatment of Diabetes Insipidus Neurogenic DI DDAVP Chlorpropamide (Diabinese) Nephrogenic DI Not affected by treatment with DDAVP or chlorpropamide May be reduced by treatment with a thiazide diuretic and/or amiloride in conjunction with a low-sodium diet Inhibitors of prostaglandin synthesis (e.g., indomethacin) are also effective in some patients Thank You